Meridian, IDNCT07543757Now EnrollingIRB Ready

Prostate Cancer Detection Clinical Trial in Meridian, ID

Access cutting-edge prostate cancer detection treatment through this clinical trial at a research site in Meridian. Study-provided care at no cost to qualified participants.

Sponsored by Sequenom, Inc.

Quick Self-Assessment

See if you qualify for this Meridian location

Preparing your pre-screening questions…

Expert Care in Meridian

Access prostate cancer detection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prostate cancer detection treatment provided free

Apply for This Meridian Location

Check if you qualify for this prostate cancer detection clinical trial in Meridian, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Meridian

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Meridian site if eligible
  4. 4Begin participation

About This Prostate Cancer Detection Study in Meridian

The study is a prospective, multi-center, single cohort study involving up to 10 urological clinics in the US. After provision of informed consent and prior to the scheduled prostate biopsy (≤30 days), up to 20 mL of whole blood will be collected from each subject. The samples will be blinded and sent to Labcorp for evaluation using the Proclarix® assay. Prostate biopsy will be performed according to standard clinical practice of the urologist (systematic, targeted, or combined biopsy with a transrectal or transperineal approach with or without prior magnetic resonance imaging (MRI)). A minimum of 10 cores are required. Histopathological examination of the biopsy specimen will be performed according to the established local practice. A csPCa is defined as ISUP Grade Group ≥2 detected on biopsy. The assay results will be compared to the biopsy results.

Sponsor: Sequenom, Inc.

Who Can Participate

Inclusion Criteria

Subject is male ≥40 and ≤75 years of age at the time of enrollment;
Subject provides a signed and dated informed consent;
Subject has a SOC tPSA of 2-10 ng/mL inclusive within 30 days of the Screening Visit;
Up to 100 subjects will have a SOC tPSA of 2-\<4 ng/mL
A minimum of 400 subjects will have a SOC tPSA of 4-10 ng/mL
Subject is scheduled to undergo a prostate biopsy within 30 days of the Screening Visit blood collection;
Subject agrees to provide all diagnostic test results throughout the study; and
Subject agrees to provide blood for Proclarix® and phi testing at the Screening Visit.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Meridian?

Yes, this clinical trial (NCT07543757) has an active research site in Meridian, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prostate Cancer Detection Treatment Options in Meridian, ID

If you're searching for prostate cancer detection treatment options in Meridian, ID, this clinical trial (NCT07543757) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Meridian research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer detection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prostate cancer detection clinical trials near you to find additional studies recruiting in your area.

More Prostate Cancer Trials in Meridian, ID

See all prostate cancer clinical trials recruiting in Meridian — not just this study.

Browse Prostate Cancer Trials in Meridian

Ready to Join in Meridian?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Meridian, ID